Larimar Therapeutics (LRMR) EBITDA

Price: $2.33
Market Cap: $149.19M
Avg Volume: 805.09K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.906
52W Range: $1.61-11.2
Website: Larimar Therapeutics

What is Larimar Therapeutics's EBITDA?

  • Larimar Therapeutics's annual EBITDA is $-90.89M.
  • Larimar Therapeutics's quarterly EBITDA is $-31.22M.

What is EBITDA?

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a measure of a company's overall financial performance and is used as an alternative to net income in some circumstances.

How is EBITDA calculated?

EBITDA is calculated using the following formula:

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Related Metrics

Other important metrics to assess Larimar Therapeutics's financial health include:

  • EBITDA Ratio - measures the company's EBITDA as a percentage of its revenue:
    • Annual: -
    • Quarterly: -
  • Growth EBITDA - measures the annual growth rate of the company's EBITDA:
    • Annual: -119.29%
    • Quarterly: -70.92%
  • Growth EBITDA Ratio - measures the annual growth rate of the company's EBITDA ratio:
    • Annual: 0.00%
    • Quarterly: 0.00%

These metrics provide insights into Larimar Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual EBITDA

$-90.89M

Quarterly EBITDA

$-31.22M

Larimar Therapeutics Historical EBITDA
Historical EBITDA Ratio (Annual)
Historical EBITDA Ratio (Quarterly)

Larimar Therapeutics Historical EBITDA Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year EBITDA Growth EBITDA EBITDA Ratio Growth EBITDA Ratio
2024 $-90.89M -119.29% - 0.00%
2023 $-41.45M -18.14% - 0.00%
2022 $-35.08M 30.03% - 0.00%
2021 $-50.14M -17.56% - 0.00%
2020 $-42.65M -84.34% - 0.00%
2019 $-23.14M 61.95% - 0.00%
2018 $-60.81M -15.66% - 0.00%
2017 $-52.58M 8.46% - 0.00%
2016 $-57.44M 21.76% - 0.00%
2015 $-73.41M -106.60% - 0.00%

Related Metrics

Explore detailed financial metrics and analysis for LRMR.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio